Scleroderma Clinical Trials

A listing of Scleroderma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 174 clinical trials
None
Prevalence of Hyperprolactinemia in Systemic Scleroderma

Systemic sclerosis is an autoimmune and inflammatory disease characterized primarily by fibrosis and vascular involvement. We know that the immune system is disrupted in systemic sclerosis, but

fibrosis
Accepts healthy volunteers
scleroderma
  • 0 views
  • 19 Oct, 2021
  • 1 location
None
Metabolomic Analysis of Systemic Sclerosis

Currently investigators do not have diagnostic and prognostic markers for SSc which almost always starts with a vascular disease (Raynaud's disease) isolated for several years. The primary purpose is to highlight discriminating metabolic profiles depending on the characteristics of the disease, allowing early diagnosis of SSc at the onset of …

vascular disorder
scleroderma
rheumatism
raynaud phenomenon
myocardial infarction
  • 196 views
  • 11 Sep, 2021
  • 5 locations
None
Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma

To make an updated inventory of digital ulcer care protocols in scleroderma patients and to specify the French data on monthly healing rates and local care with patients in care centers

  • 0 views
  • 28 Jan, 2021
  • 2 locations
None
Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.

Diffuse infiltrating pneumonia (DIP) is a severe complication of systemic sclerosis and one of the leading cause of death in this condition. The main objective of this study is to prospectively

progressive systemic sclerosis
scleroderma
pulmonary function test
  • 0 views
  • 10 Oct, 2021
  • 3 locations
None
Assessment of Nutritional Status in Systemic Sclerosis

The main theme of the cohort of systemic sclerosis (SSc) patients is the determination of nutritional status, its evolution and the evaluation of its management in patients with scleroderma.

pulmonary function test
scleroderma
rheumatism
progressive systemic sclerosis
  • 42 views
  • 08 Sep, 2021
  • 1 location
None
Scleroderma Registry & Repository at the Hospital for Special Surgery

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS

scleroderma
rheumatism
rheumatic diseases
  • 84 views
  • 10 Oct, 2021
  • 1 location
None
Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD

) to determine if 50 scleroderma patients without evidence of lung disease who have evidence of small airway inflammation or impairment to airflow are more likely to develop ILD than those with normal

  • 0 views
  • 27 Jan, 2021
  • 1 location
None
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

This observational study is being done to understand why people with scleroderma can develop pulmonary arterial hypertension (high blood pressure in the lungs, abbreviated PAH) and a weak heart

hypertension
scleroderma
  • 0 views
  • 06 Nov, 2021
  • 1 location
None
Systemic Sclerosis and Jak Inhibitors : Emphasis on Macrophages

The Sclero-JAK project aims to assess the impact of a JAK1/2 inhibitor (ruxolitinib) on activation states of monocytes-derived macrophages (MDM) from systemic sclerosis (SSc) patients

  • 0 views
  • 26 Mar, 2021
  • 1 location
None
Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients

composition of the microbiota could contribute to the pathophysiology of systemic autoimmune diseases such as Systemic Sclerosis (SCS). A future exploration of the microbiota, a source of diagnostic and/or

  • 0 views
  • 23 Jan, 2021
  • 1 location